"use strict";(self.webpackChunkualcanmobile=self.webpackChunkualcanmobile||[]).push([[6240],{6240:(d,i,n)=>{n.r(i),n.d(i,{TutorialPageModule:()=>a});var t=n(2723),c=n(2598),l=n(6895),s=n(433),e=n(8256);class r{constructor(){}static \u0275fac=function(o){return new(o||r)};static \u0275cmp=e.Xpm({type:r,selectors:[["app-tutorial"]],decls:31,vars:0,consts:[[2,"text-align","center"],[1,"citation-card"],["href","#","onclick","window.open('https://www.ncbi.nlm.nih.gov/pubmed/28732212', '_system', 'location=yes'); return false;",1,"ion-home","color-primary","item"]],template:function(o,u){1&o&&(e.TgZ(0,"ion-header")(1,"ion-toolbar")(2,"ion-title",0),e._uU(3," Tutorial "),e.qZA()()(),e.TgZ(4,"ion-content")(5,"ion-card",1)(6,"ion-card-header")(7,"ion-card-title"),e._uU(8,"Welcome to UALCAN User Guide!"),e.qZA()(),e.TgZ(9,"ul")(10,"li"),e._uU(11," How to obtain list of top differentially expressed genes?"),e.qZA(),e.TgZ(12,"li"),e._uU(13,"How to query UALCAN for gene(s) of interest in specific cancer?"),e.qZA(),e.TgZ(14,"p"),e._uU(15,"a. How to explore expression profile of gene of interest based on clinico-pathologic factors? "),e.qZA(),e.TgZ(16,"p"),e._uU(17,"b. How to obtain Kaplan meier plot from UALCAN? "),e.qZA(),e.TgZ(18,"p"),e._uU(19,"c. How to obtain promoter DNA methylation level from UALCAN? "),e.qZA(),e.TgZ(20,"p"),e._uU(21,"d. How to obtain list of positive and negatively correlated genes from UALCAN?"),e.qZA(),e.TgZ(22,"li"),e._uU(23,"How to obtain expression and survival profile for pre-compiled gene classes?"),e.qZA(),e.TgZ(24,"li"),e._uU(25,"Introduction of Cancer terms"),e.qZA()(),e.TgZ(26,"ion-card-content")(27,"p"),e._uU(28,"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP, Chakravarthi BVSK and Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017 Aug;19(8):649-658. doi: 10.1016/j.neo.2017.05.002"),e.TgZ(29,"a",2),e._uU(30," [PMID:28732212]"),e.qZA()()()()())},dependencies:[t.PM,t.FN,t.Zi,t.Dq,t.W2,t.Gu,t.wd,t.sr],styles:[".welcome-card[_ngcontent-%COMP%]   ion-img[_ngcontent-%COMP%]{max-height:35vh;overflow:hidden}.welcome-card[_ngcontent-%COMP%]   ion-card-title[_ngcontent-%COMP%]{text-align:center}.citation-card[_ngcontent-%COMP%]   ion-card-title[_ngcontent-%COMP%]{text-align:center}.footer[_ngcontent-%COMP%]{text-align:center;background-image:repeating-linear-gradient(to top,rgb(197,199,255) 0%,rgb(182,180,243) 5.8%,rgb(254,254,254) 5.8%,rgb(253,253,253) 92.4%,rgb(160,164,233) 94%,rgb(157,162,238) 99.6%);background-image:-ms-repeating-linear-gradient(bottom,rgb(197,199,255) 0%,rgb(182,180,243) 5.8%,rgb(254,254,254) 5.8%,rgb(253,253,253) 92.4%,rgb(160,164,233) 94%,rgb(157,162,238) 99.6%)}.logo-card[_ngcontent-%COMP%]{height:50px;text-align:center;background-image:url(/assets/ualcan-logo.jpeg) no-repeat}.update[_ngcontent-%COMP%]{text-align:center}ion-header[_ngcontent-%COMP%]{background-image:repeating-linear-gradient(to top,rgb(197,199,255) 0%,rgb(182,180,243) 5.8%,rgb(254,254,254) 5.8%,rgb(253,253,253) 92.4%,rgb(160,164,233) 94%,rgb(157,162,238) 99.6%);background-image:-ms-repeating-linear-gradient(bottom,rgb(197,199,255) 0%,rgb(182,180,243) 5.8%,rgb(254,254,254) 5.8%,rgb(253,253,253) 92.4%,rgb(160,164,233) 94%,rgb(157,162,238) 99.6%)}.header-logo[_ngcontent-%COMP%]{background-image:url(/assets/header1.png)}ion-header[_ngcontent-%COMP%]   p[_ngcontent-%COMP%]{font:25px sans-serif;font-weight:700;text-align:center}ion-card[_ngcontent-%COMP%]{border:solid;border-color:#2ed4f1;border-width:3px}ion-card-title[_ngcontent-%COMP%]{font-weight:500}p[_ngcontent-%COMP%]{color:#000}"]})}class a{static \u0275fac=function(o){return new(o||a)};static \u0275mod=e.oAB({type:a});static \u0275inj=e.cJS({imports:[t.Pc,l.ez,s.u5,c.Bz.forChild([{path:"",component:r}])]})}}}]);